CYCLERION THERAPEUTICS, INC. Number of Reportable Segments
CYCLERION THERAPEUTICS, INC. (CYCN) reported Number of Reportable Segments of 1 Segment for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-05.
Discontinued › Notes
us-gaap:NumberOfReportableSegments · last filed 2024-03-05
- CYCLERION THERAPEUTICS, INC. number of reportable segments for the quarter ending 2019-03-31 was 1.00 segment.
- CYCLERION THERAPEUTICS, INC. number of reportable segments for fiscal 2020 was 1.00 segment, a 0.00% change from fiscal 2019.
- CYCLERION THERAPEUTICS, INC. number of reportable segments for fiscal 2019 was 1.00 segment.
segment
| Period end | Number of Reportable Segments 3 month | Number of Reportable Segments 6 month | Number of Reportable Segments 9 month | Number of Reportable Segments 12 month |
|---|---|---|---|---|
| 2020-12-31 | 1.00 segment 10-K · filed 2021-02-25 | |||
| 2019-12-31 | 1.00 segment 10-K · filed 2020-03-12 | |||
| 2019-09-30 | 1.00 segment 10-Q · filed 2019-11-12 | |||
| 2019-06-30 | 1.00 segment 10-Q · filed 2019-08-12 | |||
| 2019-03-31 | 1.00 segment 10-Q · filed 2019-05-13 |
Segment
| Period end | Number of Reportable Segments 12 month |
|---|---|
| 2023-12-31 | 1.00 Segment 10-K · filed 2024-03-05 |
| 2022-12-31 | 1.00 Segment 10-K · filed 2023-03-22 |
| 2021-12-31 | 1.00 Segment 10-K · filed 2022-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |